NCT00921986 Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic
| NCT ID | NCT00921986 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Cleveland Clinic |
| Condition | Arrhythmias, Cardiac |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2009-03 |
| Primary Completion | 2035-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2009-03 with a primary completion date of 2035-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Biorepository of blood and or tissue samples from patients presenting with cardiac arrhythmia syndromes.
Eligibility Criteria
Inclusion Criteria: * Male or female at least 18 years old * Subjects with a history of or current cardiac arrhythmia, family members of subjects with cardiac arrhythmias, or no cardiac arrhythmia if a Control Subject. Exclusion Criteria: * Subjects previously enrolled in the Arrhythmia BioBank
Contact & Investigator
Mina K. Chung, MD
PRINCIPAL INVESTIGATOR
The Cleveland Clinic
Frequently Asked Questions
Who can join the NCT00921986 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Arrhythmias, Cardiac. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00921986 currently recruiting?
Yes, NCT00921986 is actively recruiting participants. Contact the research team at chungm@ccf.org for enrollment information.
Where is the NCT00921986 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT00921986 clinical trial?
NCT00921986 is sponsored by The Cleveland Clinic. The principal investigator is Mina K. Chung, MD at The Cleveland Clinic. The trial plans to enroll 2,000 participants.